Brianne Ozaki
Nurse Practitioner · Spokane Valley, WANPI 1871931543
Payments from drug & device makers
Across 126 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$370
- Pharmacyclics LLC, An Abbvie Company$249
- Lilly USA, LLC$212
- Genentech USA, Inc.$204
- Bristol Myers Squibb$162
- Incyte Corporation$137
- plus $1K from 32 others
What the payments were for
- Food & beverage$2,42588%
- Education$31712%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 16 | $370 |
| Pharmacyclics LLC, An Abbvie Company | 11 | $249 |
| Lilly USA, LLC | 7 | $212 |
| Genentech USA, Inc. | 10 | $204 |
| Bristol Myers Squibb | 8 | $162 |
| Incyte Corporation | 3 | $137 |
| Astellas Pharma US Inc | 4 | $108 |
| E.r. Squibb & Sons, L.L.C. | 6 | $106 |
| Seagen Inc. | 7 | $104 |
| Johnson & Johnson | 5 | $91 |
| Boehringer Ingelheim | 3 | $75 |
| AstraZeneca | 3 | $71 |
| Exelixis Inc. | 3 | $62 |
| Gilead | 2 | $50 |
| Merck | 3 | $50 |
| AbbVie | 2 | $48 |
| Taiho Oncology, Inc. | 3 | $46 |
| GSK | 2 | $44 |
| Morphosys, US Inc. | 3 | $43 |
| Deciphera Pharmaceuticals Inc. | 2 | $41 |
| Bayer | 2 | $38 |
| Myriad Genetic Laboratories, Inc. | 2 | $36 |
| Pfizer | 2 | $36 |
| EMD Serono, Inc. | 2 | $35 |
| Eisai Inc. | 2 | $35 |
| Pharmacosmos Therapeutics Inc. | 1 | $34 |
| Stryker | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Progenics Pharmaceuticals, Inc. | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Epizyme, Inc. | 1 | $21 |
| Sanofi | 1 | $21 |
| G1 Therapeutics, Inc. | 1 | $20 |
| Amgen | 1 | $19 |
| EUSA Pharma (US) LLC | 1 | $16 |
| Beigene USA, Inc. | 1 | $16 |
| Puma Biotechnology, Inc. | 1 | $14 |
How this compares
$2,743 in reported general payments places this provider in the 95th percentile of 2,466 nurse practitioner providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nurse practitioner in Spokane Valley
- Jennifer LazzaraSpokane Valley$11K
- Darla ChapmanSeattle$541K
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Wayne ClarkYakima$232K
- Felicia ForrestLynnwood$206K
- Amaris MurphyBellevue$146K
- Sonia GlennieSeattle$78K
- Megan WildesTacoma$72K
- Kate KennedyBellevue$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.